Dianne M. Nast Appointed to Plaintiff's Steering Committee in Xarelto Litigation

PHILADELPHIA, Feb. 10, 2015 /PRNewswire/ -- Philadelphia lawyer Dianne M. Nast of NastLaw LLC has been appointed to the Plaintiff's Steering Committee in the litigation against Xarelto®, a widely prescribed blood thinning medication manufactured by Bayer and marketed by Janssen. Federal Judge Eldon E. Fallon of Louisiana made the Plaintiff's Steering Committee appointments and also appointed Philadelphia lawyers Frederick Longer of Levin, Fishbein, Sedran & Berman, and Dr. Mark Alan Hoffman of Ross Feller Casey LLP.

Ms. Nast and NastLaw LLC represent the families of individuals who died after taking Xarelto. The drug has been linked to hundreds of deaths since it was approved in 2011. The lawsuits allege that through their advertising, Janssen and Bayer failed to disclose adequately that there is no means to reverse the anticoagulation effects of Xarelto.

With no known antidote to stop the bleeding, patients who are taking Xarelto can bleed to death from wounds that would not normally be fatal. Unlike other drugs in its category, Xarelto does not require testing that would determine if patients are predisposed to adverse events from bleeding.

According to the lawsuit, prescribing physicians and millions of their patients were not warned about all of the risks of Xarelto. In 2012 alone, over 2,000 serious adverse events were reported from Xarelto, including 151 deaths. Despite the hundreds of deaths linked to Xarelto, its manufacturers continue to market the product to drive more sales. In Q4 2014 alone, Xarelto brought in $414 million for Bayer and Janssen, a 68% increase year over year.

Ms. Nast is known for her leadership in cases like the one against Xarelto. Ms. Nast currently holds positions on the Executive Committee in the General Motors Recall litigation, the Plaintiffs Steering Committee in the national Prescription Testosterone Litigation, and the Lipitor Plaintiffs' Committee. Ms. Nast also serves as Co-Lead Counsel in the Zoloft SSRI Birth Defect Litigation, Co-Lead Counsel and Federal-State Liaison and on the Advisory Committee in the Avandia Product Liability Litigation. Ms. Nast is also an active Steering Committee member in the Philadelphia-based NFL Concussion Litigation, where she serves as SubClass Counsel for injured players.

NastLaw LLC is located at 1101 Market Street, Suite 2801, Philadelphia, Pennsylvania 19107. NastLaw LLC focuses its practice in antitrust and mass tort law, including pharmaceutical product liability, medical device product liability, price fixing and other wrongful business practices.

Press Contact:
Dianne M. Nast or
Daniel Gallucci
215-923-9300
[email protected]
www.NastLaw.com

Photo - http://photos.prnewswire.com/prnh/20150210/174680

SOURCE NastLaw LLC

Related Links

http://www.NastLaw.com